Organogenesis Holdings (ORGO) Accumulated Expenses (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Accumulated Expenses of $37.7 million for Q1 2026, up 21.03% year-over-year from $31.1 million in Q1 2025, and down 23.92% quarter-over-quarter from $49.5 million in Q4 2025.
Organogenesis Holdings (ORGO) Accumulated Expenses (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Accumulated Expenses history runs 12 years deep, the most recent figure standing at $37.7 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 21.03% year-over-year to $37.7 million; the TTM figure through Mar 2026 stood at $37.7 million (up 21.03% YoY), while the FY2025 annual figure was $49.5 million, up 25.55% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $37.7 million, down from $49.5 million in the prior quarter.
- The five-year high for Accumulated Expenses was $49.5 million in Q4 2025, with the low at $26.3 million in Q2 2025.
- The 5-year median for Accumulated Expenses is $35.0 million (2023), against an average of $34.8 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 39.03% in 2024, then slumped 30.69% in 2025.
- Organogenesis Holdings' Accumulated Expenses stood at $26.4 million in 2022, then grew by 13.71% to $30.1 million in 2023, then surged by 31.19% to $39.5 million in 2024, then grew by 25.55% to $49.5 million in 2025, then dropped by 23.92% to $37.7 million in 2026.
- Business Quant data shows ORGO's Accumulated Expenses at $37.7 million in Q1 2026, $49.5 million in Q4 2025, and $40.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.36 Mn |
| Mar 31, 2026 | 37.68 Mn |
| Dec 31, 2025 | 49.53 Mn |
| Sep 30, 2025 | 40.31 Mn |
| Jun 30, 2025 | 26.35 Mn |
| Mar 31, 2025 | 31.14 Mn |
| Dec 31, 2024 | 39.45 Mn |
| Sep 30, 2024 | 36.10 Mn |
| Jun 30, 2024 | 38.02 Mn |
| Mar 31, 2024 | 39.76 Mn |
| Dec 31, 2023 | 30.07 Mn |
| Sep 30, 2023 | 34.99 Mn |
| Jun 30, 2023 | 27.78 Mn |
| Mar 31, 2023 | 28.60 Mn |
| Dec 31, 2022 | 26.45 Mn |
| Sep 30, 2022 | 34.16 Mn |
| Jun 30, 2022 | 36.39 Mn |
| Mar 31, 2022 | 34.12 Mn |
| Dec 31, 2021 | 37.29 Mn |
| Sep 30, 2021 | 37.13 Mn |